Summit Therapeutics hits possible snag on lung cancer drug seen as blockbuster

Summit Therapeutics may have a geography problem with its lung cancer drug ivonescimab. In a study update reported Sunday, patients from North America and Europe treated with the drug saw their lung cancer return and progress faster than patients fro... [435 chars]